Ubs Asset Management Americas Inc Immunity Bio, Inc. Transaction History
Ubs Asset Management Americas Inc
- $417 Billion
- Q4 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 261,734 shares of IBRX stock, worth $895,130. This represents 0.0% of its overall portfolio holdings.
Number of Shares
261,734
Previous 1,544,802
83.06%
Holding current value
$895,130
Previous $5.73 Million
88.31%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding IBRX
# of Institutions
229Shares Held
82.3MCall Options Held
1.02MPut Options Held
2.25M-
Vanguard Group Inc Valley Forge, PA17.3MShares$59.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$39.1 Million0.0% of portfolio
-
State Street Corp Boston, MA9.79MShares$33.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.01MShares$13.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.84MShares$13.1 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.37B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...